Global Long-acting and Short-acting Oral Contraceptives Supply, Demand and Key Producers, 2023-2029

Page: 111

Published Date: 06 Sep 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Long-acting and Short-acting Oral Contraceptives market size is expected to reach $ 781.6 million by 2029, rising at a market growth of 3.2% CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Oral contraceptives (birth control pills) are hormone-containing medications that are taken by mouth to prevent pregnancy. They prevent pregnancy by inhibiting ovulation and also by preventing sperm from penetrating through the cervix.

This report studies the global Long-acting and Short-acting Oral Contraceptives production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Long-acting and Short-acting Oral Contraceptives, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Long-acting and Short-acting Oral Contraceptives that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Long-acting and Short-acting Oral Contraceptives total production and demand, 2018-2029, (K Units)
Global Long-acting and Short-acting Oral Contraceptives total production value, 2018-2029, (USD Million)
Global Long-acting and Short-acting Oral Contraceptives production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Long-acting and Short-acting Oral Contraceptives consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Long-acting and Short-acting Oral Contraceptives domestic production, consumption, key domestic manufacturers and share
Global Long-acting and Short-acting Oral Contraceptives production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Long-acting and Short-acting Oral Contraceptives production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Long-acting and Short-acting Oral Contraceptives production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Long-acting and Short-acting Oral Contraceptives market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Paladin Labs, Theramex (Teva), Pfizer, Apotex, HRA Pharma, HLL Life Care, Mankind and Piramal, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Long-acting and Short-acting Oral Contraceptives market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Long-acting and Short-acting Oral Contraceptives Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Long-acting and Short-acting Oral Contraceptives Market, Segmentation by Type
    Combined Contraceptive Pill
    Low Dose Oral Contraceptive

Global Long-acting and Short-acting Oral Contraceptives Market, Segmentation by Application
    Hospital Pharmacies
    Private Clinics
    Retail Pharmacies
    E-Commerce

Companies Profiled:
    Bayer
    Paladin Labs
    Theramex (Teva)
    Pfizer
    Apotex
    HRA Pharma
    HLL Life Care
    Mankind
    Piramal
    Allergan

Key Questions Answered
1. How big is the global Long-acting and Short-acting Oral Contraceptives market?
2. What is the demand of the global Long-acting and Short-acting Oral Contraceptives market?
3. What is the year over year growth of the global Long-acting and Short-acting Oral Contraceptives market?
4. What is the production and production value of the global Long-acting and Short-acting Oral Contraceptives market?
5. Who are the key producers in the global Long-acting and Short-acting Oral Contraceptives market?

Table of Contents

1 Supply Summary
    1.1 Long-acting and Short-acting Oral Contraceptives Introduction
    1.2 World Long-acting and Short-acting Oral Contraceptives Supply & Forecast
        1.2.1 World Long-acting and Short-acting Oral Contraceptives Production Value (2018 & 2022 & 2029)
        1.2.2 World Long-acting and Short-acting Oral Contraceptives Production (2018-2029)
        1.2.3 World Long-acting and Short-acting Oral Contraceptives Pricing Trends (2018-2029)
    1.3 World Long-acting and Short-acting Oral Contraceptives Production by Region (Based on Production Site)
        1.3.1 World Long-acting and Short-acting Oral Contraceptives Production Value by Region (2018-2029)
        1.3.2 World Long-acting and Short-acting Oral Contraceptives Production by Region (2018-2029)
        1.3.3 World Long-acting and Short-acting Oral Contraceptives Average Price by Region (2018-2029)
        1.3.4 North America Long-acting and Short-acting Oral Contraceptives Production (2018-2029)
        1.3.5 Europe Long-acting and Short-acting Oral Contraceptives Production (2018-2029)
        1.3.6 China Long-acting and Short-acting Oral Contraceptives Production (2018-2029)
        1.3.7 Japan Long-acting and Short-acting Oral Contraceptives Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Long-acting and Short-acting Oral Contraceptives Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Long-acting and Short-acting Oral Contraceptives Major Market Trends

2 Demand Summary
    2.1 World Long-acting and Short-acting Oral Contraceptives Demand (2018-2029)
    2.2 World Long-acting and Short-acting Oral Contraceptives Consumption by Region
        2.2.1 World Long-acting and Short-acting Oral Contraceptives Consumption by Region (2018-2023)
        2.2.2 World Long-acting and Short-acting Oral Contraceptives Consumption Forecast by Region (2024-2029)
    2.3 United States Long-acting and Short-acting Oral Contraceptives Consumption (2018-2029)
    2.4 China Long-acting and Short-acting Oral Contraceptives Consumption (2018-2029)
    2.5 Europe Long-acting and Short-acting Oral Contraceptives Consumption (2018-2029)
    2.6 Japan Long-acting and Short-acting Oral Contraceptives Consumption (2018-2029)
    2.7 South Korea Long-acting and Short-acting Oral Contraceptives Consumption (2018-2029)
    2.8 ASEAN Long-acting and Short-acting Oral Contraceptives Consumption (2018-2029)
    2.9 India Long-acting and Short-acting Oral Contraceptives Consumption (2018-2029)

3 World Long-acting and Short-acting Oral Contraceptives Manufacturers Competitive Analysis
    3.1 World Long-acting and Short-acting Oral Contraceptives Production Value by Manufacturer (2018-2023)
    3.2 World Long-acting and Short-acting Oral Contraceptives Production by Manufacturer (2018-2023)
    3.3 World Long-acting and Short-acting Oral Contraceptives Average Price by Manufacturer (2018-2023)
    3.4 Long-acting and Short-acting Oral Contraceptives Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Long-acting and Short-acting Oral Contraceptives Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Long-acting and Short-acting Oral Contraceptives in 2022
        3.5.3 Global Concentration Ratios (CR8) for Long-acting and Short-acting Oral Contraceptives in 2022
    3.6 Long-acting and Short-acting Oral Contraceptives Market: Overall Company Footprint Analysis
        3.6.1 Long-acting and Short-acting Oral Contraceptives Market: Region Footprint
        3.6.2 Long-acting and Short-acting Oral Contraceptives Market: Company Product Type Footprint
        3.6.3 Long-acting and Short-acting Oral Contraceptives Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Long-acting and Short-acting Oral Contraceptives Production Value Comparison
        4.1.1 United States VS China: Long-acting and Short-acting Oral Contraceptives Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Long-acting and Short-acting Oral Contraceptives Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Long-acting and Short-acting Oral Contraceptives Production Comparison
        4.2.1 United States VS China: Long-acting and Short-acting Oral Contraceptives Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Long-acting and Short-acting Oral Contraceptives Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Long-acting and Short-acting Oral Contraceptives Consumption Comparison
        4.3.1 United States VS China: Long-acting and Short-acting Oral Contraceptives Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Long-acting and Short-acting Oral Contraceptives Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Long-acting and Short-acting Oral Contraceptives Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Long-acting and Short-acting Oral Contraceptives Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production (2018-2023)
    4.5 China Based Long-acting and Short-acting Oral Contraceptives Manufacturers and Market Share
        4.5.1 China Based Long-acting and Short-acting Oral Contraceptives Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production Value (2018-2023)
        4.5.3 China Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production (2018-2023)
    4.6 Rest of World Based Long-acting and Short-acting Oral Contraceptives Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Long-acting and Short-acting Oral Contraceptives Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production (2018-2023)

5 Market Analysis by Type
    5.1 World Long-acting and Short-acting Oral Contraceptives Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Combined Contraceptive Pill
        5.2.2 Low Dose Oral Contraceptive
    5.3 Market Segment by Type
        5.3.1 World Long-acting and Short-acting Oral Contraceptives Production by Type (2018-2029)
        5.3.2 World Long-acting and Short-acting Oral Contraceptives Production Value by Type (2018-2029)
        5.3.3 World Long-acting and Short-acting Oral Contraceptives Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Long-acting and Short-acting Oral Contraceptives Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacies
        6.2.2 Private Clinics
        6.2.3 Retail Pharmacies
        6.2.4 E-Commerce
    6.3 Market Segment by Application
        6.3.1 World Long-acting and Short-acting Oral Contraceptives Production by Application (2018-2029)
        6.3.2 World Long-acting and Short-acting Oral Contraceptives Production Value by Application (2018-2029)
        6.3.3 World Long-acting and Short-acting Oral Contraceptives Average Price by Application (2018-2029)

7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Details
        7.1.2 Bayer Major Business
        7.1.3 Bayer Long-acting and Short-acting Oral Contraceptives Product and Services
        7.1.4 Bayer Long-acting and Short-acting Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 Bayer Recent Developments/Updates
        7.1.6 Bayer Competitive Strengths & Weaknesses
    7.2 Paladin Labs
        7.2.1 Paladin Labs Details
        7.2.2 Paladin Labs Major Business
        7.2.3 Paladin Labs Long-acting and Short-acting Oral Contraceptives Product and Services
        7.2.4 Paladin Labs Long-acting and Short-acting Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Paladin Labs Recent Developments/Updates
        7.2.6 Paladin Labs Competitive Strengths & Weaknesses
    7.3 Theramex (Teva)
        7.3.1 Theramex (Teva) Details
        7.3.2 Theramex (Teva) Major Business
        7.3.3 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product and Services
        7.3.4 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Theramex (Teva) Recent Developments/Updates
        7.3.6 Theramex (Teva) Competitive Strengths & Weaknesses
    7.4 Pfizer
        7.4.1 Pfizer Details
        7.4.2 Pfizer Major Business
        7.4.3 Pfizer Long-acting and Short-acting Oral Contraceptives Product and Services
        7.4.4 Pfizer Long-acting and Short-acting Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Pfizer Recent Developments/Updates
        7.4.6 Pfizer Competitive Strengths & Weaknesses
    7.5 Apotex
        7.5.1 Apotex Details
        7.5.2 Apotex Major Business
        7.5.3 Apotex Long-acting and Short-acting Oral Contraceptives Product and Services
        7.5.4 Apotex Long-acting and Short-acting Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Apotex Recent Developments/Updates
        7.5.6 Apotex Competitive Strengths & Weaknesses
    7.6 HRA Pharma
        7.6.1 HRA Pharma Details
        7.6.2 HRA Pharma Major Business
        7.6.3 HRA Pharma Long-acting and Short-acting Oral Contraceptives Product and Services
        7.6.4 HRA Pharma Long-acting and Short-acting Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 HRA Pharma Recent Developments/Updates
        7.6.6 HRA Pharma Competitive Strengths & Weaknesses
    7.7 HLL Life Care
        7.7.1 HLL Life Care Details
        7.7.2 HLL Life Care Major Business
        7.7.3 HLL Life Care Long-acting and Short-acting Oral Contraceptives Product and Services
        7.7.4 HLL Life Care Long-acting and Short-acting Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 HLL Life Care Recent Developments/Updates
        7.7.6 HLL Life Care Competitive Strengths & Weaknesses
    7.8 Mankind
        7.8.1 Mankind Details
        7.8.2 Mankind Major Business
        7.8.3 Mankind Long-acting and Short-acting Oral Contraceptives Product and Services
        7.8.4 Mankind Long-acting and Short-acting Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 Mankind Recent Developments/Updates
        7.8.6 Mankind Competitive Strengths & Weaknesses
    7.9 Piramal
        7.9.1 Piramal Details
        7.9.2 Piramal Major Business
        7.9.3 Piramal Long-acting and Short-acting Oral Contraceptives Product and Services
        7.9.4 Piramal Long-acting and Short-acting Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Piramal Recent Developments/Updates
        7.9.6 Piramal Competitive Strengths & Weaknesses
    7.10 Allergan
        7.10.1 Allergan Details
        7.10.2 Allergan Major Business
        7.10.3 Allergan Long-acting and Short-acting Oral Contraceptives Product and Services
        7.10.4 Allergan Long-acting and Short-acting Oral Contraceptives Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Allergan Recent Developments/Updates
        7.10.6 Allergan Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Long-acting and Short-acting Oral Contraceptives Industry Chain
    8.2 Long-acting and Short-acting Oral Contraceptives Upstream Analysis
        8.2.1 Long-acting and Short-acting Oral Contraceptives Core Raw Materials
        8.2.2 Main Manufacturers of Long-acting and Short-acting Oral Contraceptives Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Long-acting and Short-acting Oral Contraceptives Production Mode
    8.6 Long-acting and Short-acting Oral Contraceptives Procurement Model
    8.7 Long-acting and Short-acting Oral Contraceptives Industry Sales Model and Sales Channels
        8.7.1 Long-acting and Short-acting Oral Contraceptives Sales Model
        8.7.2 Long-acting and Short-acting Oral Contraceptives Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Long-acting and Short-acting Oral Contraceptives Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Long-acting and Short-acting Oral Contraceptives Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Long-acting and Short-acting Oral Contraceptives Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Long-acting and Short-acting Oral Contraceptives Production Value Market Share by Region (2018-2023)
    Table 5. World Long-acting and Short-acting Oral Contraceptives Production Value Market Share by Region (2024-2029)
    Table 6. World Long-acting and Short-acting Oral Contraceptives Production by Region (2018-2023) & (K Units)
    Table 7. World Long-acting and Short-acting Oral Contraceptives Production by Region (2024-2029) & (K Units)
    Table 8. World Long-acting and Short-acting Oral Contraceptives Production Market Share by Region (2018-2023)
    Table 9. World Long-acting and Short-acting Oral Contraceptives Production Market Share by Region (2024-2029)
    Table 10. World Long-acting and Short-acting Oral Contraceptives Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Long-acting and Short-acting Oral Contraceptives Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Long-acting and Short-acting Oral Contraceptives Major Market Trends
    Table 13. World Long-acting and Short-acting Oral Contraceptives Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Long-acting and Short-acting Oral Contraceptives Consumption by Region (2018-2023) & (K Units)
    Table 15. World Long-acting and Short-acting Oral Contraceptives Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Long-acting and Short-acting Oral Contraceptives Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Long-acting and Short-acting Oral Contraceptives Producers in 2022
    Table 18. World Long-acting and Short-acting Oral Contraceptives Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Long-acting and Short-acting Oral Contraceptives Producers in 2022
    Table 20. World Long-acting and Short-acting Oral Contraceptives Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Long-acting and Short-acting Oral Contraceptives Company Evaluation Quadrant
    Table 22. World Long-acting and Short-acting Oral Contraceptives Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Long-acting and Short-acting Oral Contraceptives Production Site of Key Manufacturer
    Table 24. Long-acting and Short-acting Oral Contraceptives Market: Company Product Type Footprint
    Table 25. Long-acting and Short-acting Oral Contraceptives Market: Company Product Application Footprint
    Table 26. Long-acting and Short-acting Oral Contraceptives Competitive Factors
    Table 27. Long-acting and Short-acting Oral Contraceptives New Entrant and Capacity Expansion Plans
    Table 28. Long-acting and Short-acting Oral Contraceptives Mergers & Acquisitions Activity
    Table 29. United States VS China Long-acting and Short-acting Oral Contraceptives Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Long-acting and Short-acting Oral Contraceptives Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Long-acting and Short-acting Oral Contraceptives Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Long-acting and Short-acting Oral Contraceptives Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production Market Share (2018-2023)
    Table 37. China Based Long-acting and Short-acting Oral Contraceptives Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production Market Share (2018-2023)
    Table 42. Rest of World Based Long-acting and Short-acting Oral Contraceptives Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production Market Share (2018-2023)
    Table 47. World Long-acting and Short-acting Oral Contraceptives Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Long-acting and Short-acting Oral Contraceptives Production by Type (2018-2023) & (K Units)
    Table 49. World Long-acting and Short-acting Oral Contraceptives Production by Type (2024-2029) & (K Units)
    Table 50. World Long-acting and Short-acting Oral Contraceptives Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Long-acting and Short-acting Oral Contraceptives Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Long-acting and Short-acting Oral Contraceptives Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Long-acting and Short-acting Oral Contraceptives Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Long-acting and Short-acting Oral Contraceptives Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Long-acting and Short-acting Oral Contraceptives Production by Application (2018-2023) & (K Units)
    Table 56. World Long-acting and Short-acting Oral Contraceptives Production by Application (2024-2029) & (K Units)
    Table 57. World Long-acting and Short-acting Oral Contraceptives Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Long-acting and Short-acting Oral Contraceptives Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Long-acting and Short-acting Oral Contraceptives Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Long-acting and Short-acting Oral Contraceptives Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. Bayer Basic Information, Manufacturing Base and Competitors
    Table 62. Bayer Major Business
    Table 63. Bayer Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 64. Bayer Long-acting and Short-acting Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. Bayer Recent Developments/Updates
    Table 66. Bayer Competitive Strengths & Weaknesses
    Table 67. Paladin Labs Basic Information, Manufacturing Base and Competitors
    Table 68. Paladin Labs Major Business
    Table 69. Paladin Labs Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 70. Paladin Labs Long-acting and Short-acting Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Paladin Labs Recent Developments/Updates
    Table 72. Paladin Labs Competitive Strengths & Weaknesses
    Table 73. Theramex (Teva) Basic Information, Manufacturing Base and Competitors
    Table 74. Theramex (Teva) Major Business
    Table 75. Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 76. Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Theramex (Teva) Recent Developments/Updates
    Table 78. Theramex (Teva) Competitive Strengths & Weaknesses
    Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 80. Pfizer Major Business
    Table 81. Pfizer Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 82. Pfizer Long-acting and Short-acting Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Pfizer Recent Developments/Updates
    Table 84. Pfizer Competitive Strengths & Weaknesses
    Table 85. Apotex Basic Information, Manufacturing Base and Competitors
    Table 86. Apotex Major Business
    Table 87. Apotex Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 88. Apotex Long-acting and Short-acting Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Apotex Recent Developments/Updates
    Table 90. Apotex Competitive Strengths & Weaknesses
    Table 91. HRA Pharma Basic Information, Manufacturing Base and Competitors
    Table 92. HRA Pharma Major Business
    Table 93. HRA Pharma Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 94. HRA Pharma Long-acting and Short-acting Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. HRA Pharma Recent Developments/Updates
    Table 96. HRA Pharma Competitive Strengths & Weaknesses
    Table 97. HLL Life Care Basic Information, Manufacturing Base and Competitors
    Table 98. HLL Life Care Major Business
    Table 99. HLL Life Care Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 100. HLL Life Care Long-acting and Short-acting Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. HLL Life Care Recent Developments/Updates
    Table 102. HLL Life Care Competitive Strengths & Weaknesses
    Table 103. Mankind Basic Information, Manufacturing Base and Competitors
    Table 104. Mankind Major Business
    Table 105. Mankind Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 106. Mankind Long-acting and Short-acting Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. Mankind Recent Developments/Updates
    Table 108. Mankind Competitive Strengths & Weaknesses
    Table 109. Piramal Basic Information, Manufacturing Base and Competitors
    Table 110. Piramal Major Business
    Table 111. Piramal Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 112. Piramal Long-acting and Short-acting Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Piramal Recent Developments/Updates
    Table 114. Allergan Basic Information, Manufacturing Base and Competitors
    Table 115. Allergan Major Business
    Table 116. Allergan Long-acting and Short-acting Oral Contraceptives Product and Services
    Table 117. Allergan Long-acting and Short-acting Oral Contraceptives Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 118. Global Key Players of Long-acting and Short-acting Oral Contraceptives Upstream (Raw Materials)
    Table 119. Long-acting and Short-acting Oral Contraceptives Typical Customers
    Table 120. Long-acting and Short-acting Oral Contraceptives Typical Distributors
List of Figure
    Figure 1. Long-acting and Short-acting Oral Contraceptives Picture
    Figure 2. World Long-acting and Short-acting Oral Contraceptives Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Long-acting and Short-acting Oral Contraceptives Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Long-acting and Short-acting Oral Contraceptives Production (2018-2029) & (K Units)
    Figure 5. World Long-acting and Short-acting Oral Contraceptives Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Long-acting and Short-acting Oral Contraceptives Production Value Market Share by Region (2018-2029)
    Figure 7. World Long-acting and Short-acting Oral Contraceptives Production Market Share by Region (2018-2029)
    Figure 8. North America Long-acting and Short-acting Oral Contraceptives Production (2018-2029) & (K Units)
    Figure 9. Europe Long-acting and Short-acting Oral Contraceptives Production (2018-2029) & (K Units)
    Figure 10. China Long-acting and Short-acting Oral Contraceptives Production (2018-2029) & (K Units)
    Figure 11. Japan Long-acting and Short-acting Oral Contraceptives Production (2018-2029) & (K Units)
    Figure 12. Long-acting and Short-acting Oral Contraceptives Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Long-acting and Short-acting Oral Contraceptives Consumption (2018-2029) & (K Units)
    Figure 15. World Long-acting and Short-acting Oral Contraceptives Consumption Market Share by Region (2018-2029)
    Figure 16. United States Long-acting and Short-acting Oral Contraceptives Consumption (2018-2029) & (K Units)
    Figure 17. China Long-acting and Short-acting Oral Contraceptives Consumption (2018-2029) & (K Units)
    Figure 18. Europe Long-acting and Short-acting Oral Contraceptives Consumption (2018-2029) & (K Units)
    Figure 19. Japan Long-acting and Short-acting Oral Contraceptives Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Long-acting and Short-acting Oral Contraceptives Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Long-acting and Short-acting Oral Contraceptives Consumption (2018-2029) & (K Units)
    Figure 22. India Long-acting and Short-acting Oral Contraceptives Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Long-acting and Short-acting Oral Contraceptives by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Long-acting and Short-acting Oral Contraceptives Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Long-acting and Short-acting Oral Contraceptives Markets in 2022
    Figure 26. United States VS China: Long-acting and Short-acting Oral Contraceptives Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Long-acting and Short-acting Oral Contraceptives Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Long-acting and Short-acting Oral Contraceptives Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production Market Share 2022
    Figure 30. China Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Long-acting and Short-acting Oral Contraceptives Production Market Share 2022
    Figure 32. World Long-acting and Short-acting Oral Contraceptives Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Long-acting and Short-acting Oral Contraceptives Production Value Market Share by Type in 2022
    Figure 34. Combined Contraceptive Pill
    Figure 35. Low Dose Oral Contraceptive
    Figure 36. World Long-acting and Short-acting Oral Contraceptives Production Market Share by Type (2018-2029)
    Figure 37. World Long-acting and Short-acting Oral Contraceptives Production Value Market Share by Type (2018-2029)
    Figure 38. World Long-acting and Short-acting Oral Contraceptives Average Price by Type (2018-2029) & (US$/Unit)
    Figure 39. World Long-acting and Short-acting Oral Contraceptives Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Long-acting and Short-acting Oral Contraceptives Production Value Market Share by Application in 2022
    Figure 41. Hospital Pharmacies
    Figure 42. Private Clinics
    Figure 43. Retail Pharmacies
    Figure 44. E-Commerce
    Figure 45. World Long-acting and Short-acting Oral Contraceptives Production Market Share by Application (2018-2029)
    Figure 46. World Long-acting and Short-acting Oral Contraceptives Production Value Market Share by Application (2018-2029)
    Figure 47. World Long-acting and Short-acting Oral Contraceptives Average Price by Application (2018-2029) & (US$/Unit)
    Figure 48. Long-acting and Short-acting Oral Contraceptives Industry Chain
    Figure 49. Long-acting and Short-acting Oral Contraceptives Procurement Model
    Figure 50. Long-acting and Short-acting Oral Contraceptives Sales Model
    Figure 51. Long-acting and Short-acting Oral Contraceptives Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Bayer
Paladin Labs
Theramex (Teva)
Pfizer
Apotex
HRA Pharma
HLL Life Care
Mankind
Piramal
Allergan

Related Reports

Global Long-acting and Short-acting Oral Contraceptives Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Long-acting and Short-acting Oral Contraceptives Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 06 Sep 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Long-acting and Short-acting Oral Contraceptives market size was valued at USD 628.7 million in 2022 and is forecast to a readjusted size of USD 781.6 million by 2029 with a CAGR of 3.2% during review period.

Global Long-acting and Short-acting Oral Contraceptives Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Long-acting and Short-acting Oral Contraceptives Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 08 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Long-acting and Short-acting Oral Contraceptives market size was valued at USD 628.7 million in 2023 and is forecast to a readjusted size of USD 781.6 million by 2030 with a CAGR of 3.2% during review period.

Global Long-acting and Short-acting Oral Contraceptives Supply, Demand and Key Producers, 2024-2030

Global Long-acting and Short-acting Oral Contraceptives Supply, Demand and Key Producers, 2024-2030

date 12 Feb 2024

date Pharma & Healthcare

The global Long-acting and Short-acting Oral Contraceptives market size is expected to reach $ 781.6 million by 2030, rising at a market growth of 3.2% CAGR during the forecast period (2024-2030).

Product Tags

Long-acting and Short-acting Oral Contraceptives

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>